Side Effects and Tolerance
In the discussion of a drug therapy, the question of risks and side effects plays an important role. I notice that misunderstandings often occur due to different terminologies.
Continue reading
Year: 2017
The Nocebo Effect
The placebo effect is now well known – the nocebo effect, on the other hand, is probably not as familiar to many – but it represents a significant influence in medicine.
Continue reading Regarding Risks and Side Effects…
I believe that no topic is as intensely and controversially discussed in medicine as the topic of drug side effects. This discussion is absolutely understandable, as it was a long journey from the beginning of
Continue reading
News from the AAN 2017
As a rule, I try to report on international congresses within the framework of DocBlog, which are particularly relevant for MS patients. Without a doubt, this includes the meeting of the American Academy of Neurology
Continue reading
Sexual Problems in Multiple Sclerosis
Sexual dysfunction (SD) is a common problem among people with MS. Older studies from the 90s indicate a frequency (prevalence) between 40 and 90%, although the studies are difficult to compare due to different definitions
Continue reading
Daclizumab
Since the summer of last year, a new drug for the treatment of relapsing multiple sclerosis, Zinbryta® (active ingredient Daclizumab), has been on the market. Compared to the market launches of new drugs in recent
Continue readingTecfidera – Lymphocyte Levels in Clinical Practice
In my previous post, I wrote about the basic importance of the small blood count and the differential blood count (“complete blood count”) – I therefore refer to this article for a better understanding of
Continue reading
Small Excursion: The White Blood Cells
We often talk in the MS clinic about white blood cells, about leukocytes, lymphocytes, granulocytes and what they’re all called. But I always find that the background knowledge about these important cells is often incomplete,
Continue reading
“A Little Glass in Honor…” – Alcohol with MS
For many people affected by MS, nutrition is an important topic. I recently spoke about the importance of diets at a patient event. In the subsequent Q&A session, I was (rightly) pointed out that I
Continue reading
2017 – What awaits us in MS therapy
What will the new year bring? This question is not only of interest in terms of private and societal developments, but also with regard to the latest news in MS therapy research.
Continue reading
